Literature DB >> 12203398

Y1 receptor of neuropeptide Y as a glial marker in proliferative vitreoretinopathy and diseased human retina.

M Valeria Cantó Soler1, Juan E Gallo, Ricardo A Dodds, Tomas Hökfelt, Marcelo J Villar, Angela M Suburo.   

Abstract

The Y1 receptor of neuropeptide Y (NPY) has been demonstrated in glial cells of astrocytic lineage in vitro. We have studied the immunohistochemical expression of Y1 receptors in the glia of the diseased human retina, in tissue samples obtained after surgery for proliferative vitreoretinopathy. In this condition, glia and other cell types migrate and form epi- or subretinal membranes. Both diseased retinas (n = 8) and PVR membranes (n = 43) contained numerous Y1-immunoreactive cells. In the diseased retina, the Y1 antiserum labeled cells with the morphological radial pattern characteristic of Müller cells, whereas in the membranes, label appeared in a large population of elongate cells, measuring up to 250 microm. In both retina and membranes, double labeling demonstrated that the vast majority of Y1-immunoreactive cells were also labeled by a glial fibrillary acidic protein (GFAP) antibody, indicating their glial origin. Retinal regions devoid of GFAP immunoreactivity also lacked the Y1 label. None of these markers was detected in Müller cells of normal retina. Y1 immunoreactivity did not co-localize with smooth muscle actin immunoreactivity, a marker of myofibroblasts. Expression of Y1 receptors would characterize reactive and proliferating glial cells of the diseased retina and could perhaps be involved in the proliferation of injured glial cells causing regrowth of PVR membranes and the consequent secondary retinal detachments. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203398     DOI: 10.1002/glia.10107

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  9 in total

Review 1.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

2.  Effect of alpha2-macroglobulin on retinal glial cell proliferation.

Authors:  Ivan Milenkovic; Gerd Birkenmeier; Peter Wiedemann; Andreas Reichenbach; Andreas Bringmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

Review 3.  Neuropeptides and diabetic retinopathy.

Authors:  Robert Gábriel
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

4.  Blockade of endothelinergic receptors prevents development of proliferative vitreoretinopathy in mice.

Authors:  María Iribarne; Liliana Ogawa; Vanesa Torbidoni; Cristian M Dodds; Ricardo A Dodds; Angela M Suburo
Journal:  Am J Pathol       Date:  2008-02-29       Impact factor: 4.307

5.  Neuropeptide Y-evoked proliferation of retinal glial (Muller) cells.

Authors:  Ivan Milenkovic; Michael Weick; Peter Wiedemann; Andreas Reichenbach; Andreas Bringmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-04       Impact factor: 3.117

6.  Adaptogens stimulate neuropeptide y and hsp72 expression and release in neuroglia cells.

Authors:  Alexander Panossian; Georg Wikman; Punit Kaur; Alexzander Asea
Journal:  Front Neurosci       Date:  2012-02-01       Impact factor: 4.677

7.  Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro.

Authors:  João Martins; Filipe Elvas; Dan Brudzewsky; Tânia Martins; Bogdan Kolomiets; Pedro Tralhão; Casper R Gøtzsche; Cláudia Cavadas; Miguel Castelo-Branco; David P D Woldbye; Serge Picaud; Ana R Santiago; António F Ambrósio
Journal:  ASN Neuro       Date:  2015-08-26       Impact factor: 4.146

8.  Apelin in epiretinal membranes of patients with proliferative diabetic retinopathy.

Authors:  Qiang Lu; Yan Ma; Yong-Sheng Xu; Yan-Rong Jiang
Journal:  Mol Vis       Date:  2014-07-31       Impact factor: 2.367

9.  The role of apelin in the retina of diabetic rats.

Authors:  Qiang Lu; Jing Feng; Yan-Rong Jiang
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.